Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma–a systematic review
SC Clement, RP Peeters, CM Ronckers, TP Links… - Cancer treatment …, 2015 - Elsevier
Background Treatment of differentiated thyroid carcinoma (DTC) often involves
administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC …
administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC …
The evolving role of 131I for the treatment of differentiated thyroid carcinoma
RJ Robbins, MJ Schlumberger - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
The use of radioactive iodine (131 I) for the treatment of thyroid carcinoma has changed over
the past 50 y. These changes are based on increasing awareness of the biophysical …
the past 50 y. These changes are based on increasing awareness of the biophysical …
Value of post-therapy whole-body I-131 imaging in the evaluation of patients with thyroid carcinoma having undergone high-dose I-131 therapy
WG SPIES, CH WOJTOWICZ, SM SPIES… - Clinical nuclear …, 1989 - journals.lww.com
Post-therapy whole-body I-131 images were compared to 5 mCi pretherapy diagnostic
studies in 39 cases of well-differentiated thyroid carcinoma treated with I-131 to evaluate the …
studies in 39 cases of well-differentiated thyroid carcinoma treated with I-131 to evaluate the …
Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma
SI Sherman, ET Tielens, S Sostre… - The Journal of …, 1994 - academic.oup.com
A retrospective comparison was performed of whole body scans obtained before and after
143 131I treatments in 93 patients with thyroid carcinoma. Pretreatment scans were …
143 131I treatments in 93 patients with thyroid carcinoma. Pretreatment scans were …
The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer
RK Grewal, RM Tuttle, J Fox, S Borkar… - Journal of Nuclear …, 2010 - Soc Nuclear Med
The objective of this study was to determine whether posttherapy 131I SPECT/CT changed
the need for additional cross-sectional imaging or modified the American Thyroid …
the need for additional cross-sectional imaging or modified the American Thyroid …
Radioiodine: the classic theranostic agent
EB Silberstein - Seminars in nuclear medicine, 2012 - Elsevier
Radioiodine has the distinction of being the first theranostic agent in our armamentarium.
Millennia were required to discover that the agent in orally administered seaweed and its …
Millennia were required to discover that the agent in orally administered seaweed and its …